Patient Selection for Elective Revascularization to Reduce Myocardial Infarction and Mortality

Circulation: Cardiovascular Imaging

Volumn 8, Issue 5, 2015, Pages

  Gould, K Lance ^a   Johnson, Nils P ^a   Kaul, Sanjay ^b   Kirkeeide, Richard L ^a   Mintz, Gary S ^c   Rentrop, K Peter ^d,e,f   Sdringola, Stefano ^a   Virmani, Renu ^g   Narula, Jagat ^h  

^a UNIVERSITY OF TEXAS   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f Gramercy Cardiol Diagn Services   (United States)

^g CVPATH INSTITUTE   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

coronary stenosis; percutaneous coronary intervention

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ARTICLE; CARDIOLOGY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; ECHOCARDIOGRAPHY; ELECTIVE SURGERY; EVENT FREE SURVIVAL; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; INTRAVASCULAR ULTRASOUND; INVASIVE PROCEDURE; MEDICAL SOCIETY; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STATISTICS; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; STATISTICAL ANALYSIS;

CORONARY ARTERY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84937416215     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.003099     Document Type: Article

References (44)

1. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-94.
2. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354-1367.
3. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208-1217. doi: 10. 1056/ NEJMoa1408758.
4. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010;55:2435-2445. doi: 10. 1016/j. jacc. 2010. 03. 007.
5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. doi: 10. 1016/ S0140-6736(03)12113-7.
6. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651. Also 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. J Am Coll Cardiol. 2011;58:e44-e122. doi:10. 1016/j. jacc. 2011. 08. 007.
7. Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Metaanalysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med. 2010;152:370-379. doi:107326/0003-4819-152-6-201003160-00007
8. Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, Grines CL, Chambers CE; Society for Cardiovascular Angiography and Interventions. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;81:243-259. doi: 10. 1002/ccd. 24376.
9. Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Jüni P. Revascularisation versus medical treatment in patients with stable coronary artery disease: network metaanalysis. BMJ 2014;348:g3859. doi: 10. 1136/bmj. g3859.
10. Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, Messenger J, Moussa I, Garratt K, Rumsfeld J, Brindis RG. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60:2017-2031. doi:10. 1016/j. jacc. 2012. 08. 966.
11. Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, Jensen J, Nilsson T, de Smet BJ, Sjögren I, Thorvinger B, Lagerqvist B. Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary. Angiography and Angioplasty Registry). J Am Coll Cardiol. 2013;61:1222-1230. doi: 10. 1016/j. jacc. 2013. 01. 007.
12. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen SL, Di Serafino L, Domínguez-Franco AJ, Dupouy P, Esen AM, Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jiménez-Navarro MF, Katritsis DG, Kocaman SA, Koo BK, López-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, Oud N, Puymirat E, Rieber J, Rioufol G, Rodés-Cabau J, Sedlis SP, Takeishi Y, Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne B, Gould KL. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014;64:1641-1654. doi:101016/j. jacc. 2014. 07. 973
13. Toth G, Hamilos M, Pyxaras S, Mangiacapra F, Nelis O, De Vroey F, Di Serafino L, Muller O, Van Mieghem C, Wyffels E, Heyndrickx GR, Bartunek J, Vanderheyden M, Barbato E, Wijns W, De Bruyne B. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J. 2014;35:2831-2838. doi: 10. 1093/ eurheartj/ehu094.
14. Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning A, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain: the RIPCORD study. Circ Cardiovasc Interv. 2014;7:248-255. doi: 10. 1161/ CIRCINTERVENTIONS. 113. 000978.
15. Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, Champagne S, Belle L, Barreau D, Hanssen M, Besnard C, Dauphin R, Dallongeville J, El Hahi Y, Sideris G, Bretelle C, Lhoest N, Barnay P, Leborgne L, Dupouy P; Investigators of the Registre Français de la FFR-R3F. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129:173-185. doi:101161/CIRCULATIONAHA. 113. 006646
16. Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? JACC Cardiovasc Imaging. 2012;5:193-202. doi: 10. 1016/j. jcmg. 2011. 09. 020.
17. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, Blankstein R, Dorbala S, Sitek A, Pencina MJ, Di Carli MF. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215-2224. doi: 10. 1161/ CIRCULATIONAHA. 111. 050427.
18. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19-27. doi: 10. 1161/ CIRCULATIONAHA. 114. 011939.
19. Gould KL, Johnson NP. Physiologic severity of diffuse coronary artery disease: hidden high risk. Circulation. 2015;131:4-6. doi: 10. 1161/ CIRCULATIONAHA. 114. 013815.
20. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125:1147-1156. doi: 10. 1161/ CIRCULATIONAHA. 111. 047431.
21. Tian J, Ren X, Vergallo R, Xing L, Yu H, Jia H, Soeda T, McNulty I, Hu S, Lee H, Yu B, Jang IK. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol. 2014;63:2209-2216. doi: 10. 1016/j. jacc. 2014. 01. 061.
22. Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, Melikian N, Vanderheyden M, Heyndrickx GR, Wyffels E, Wijns W, De Bruyne B. Severity of coronary arterial stenoses responsible for acute coronary syndromes. Am J Cardiol. 2009;103:1183-1188. doi: 10. 1016/j. amjcard. 2008. 12. 047.
23. Finn AV, Chandrashekhar Y, Narula J. Vulnerable plaques: from PROSPECT to prospects. JACC Cardiovasc Imaging. 2012;5:334-336. doi: 10. 1016/j. jcmg. 2012. 02. 004.
24. Stone GW, Narula J. The myth of the mild vulnerable plaques. JACC Cardiovasc Imaging. 2013;6:1124-1126. doi: 10. 1016/j. jcmg. 2013. 09. 002.
25. Moreno PR, Narula J. Thinking outside the lumen: fractional flow reserve versus intravascular imaging for major adverse cardiac event prediction. J Am Coll Cardiol. 2014;63:1141-1144. doi: 10. 1016/j. jacc. 2013. 07. 072.
26. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235. doi: 10. 1056/NEJMoa1002358.
27. Mintz GS. Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not. Eur Heart J Cardiovasc Imaging. 2014;15:378-379. doi: 10. 1093/ehjci/jet291.
28. Mintz GS. Clinical utility of intravascular imaging and physiology in coronary artery disease. J Am Coll Cardiol. 2014;64:207-222. doi:101016/j. jacc. 2014. 01. 015
29. Virmani R. Are our tools for the identification of TCFA ready and do we know them? JACC Cardiovasc Imaging. 2011;4:656-658. doi: 10. 1016/j. jcmg. 2011. 01. 019.
30. De Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, Gould KL, Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation. 2001;104:2401-2406.
31. Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJ, Di Carli MF, Dorbala S, Gewirtz H, Gropler RJ, Kaufmann PA, Knaapen P, Knuuti J, Merhige ME, Rentrop KP, Ruddy TD, Schelbert HR, Schindler TH, Schwaiger M, Sdringola S, Vitarello J, Williams KA Sr, Gordon D, Dilsizian V, Narula J. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013;62:1639-1653. doi: 10. 1016/j. jacc. 2013. 07. 076.
32. Johnson NP, Gould KL. Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve. JACC Cardiovasc Imaging. 2011;4:990-998. doi: 10. 1016/j. jcmg. 2011. 06. 015.
33. Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging. 2012;5:430-440. doi:101016/j. jcmg. 2011. 12. 014
34. Sdringola S, Loghin C, Boccalandro F, Gould KL. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. J Nucl Med. 2006;47:59-67.
35. Sdringola S, Johnson NP, Narula J, Gould KL. Serial quantitative assessment of absolute coronary flow and flow reserve with CAD progressionto events. JACC Cardiovasc Imaging. 2013;6:735-738. doi: 10. 1016/j. jcmg. 2012. 07. 019.
36. Johnson NP, Kirkeeide RL, Gould KL. Coronary anatomy to predict physiology: fundamental limits. Circ Cardiovasc Imaging. 2013;6:817-832. doi: 10. 1161/CIRCIMAGING. 113. 000373.
37. Fleming RM, Kirkeeide RL, Smalling RW, Gould KL. Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. J Am Coll Cardiol. 1991;18:945-951.
38. Shah AP, Shavelle DM, French WJ. PCI for stable coronary disease. N Engl J Med. 2007;357:415-416; author reply 417.
39. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516. doi:101056/NEJMoa070829.
40. Inducible Myocardial Ischemia and Outcomes in Patients With Coronary Artery Disease and Left Ventricular Dysfunction-Substudy of STICH With Reversible Ischemia by SPECT. J Am Coll Cardiol. 2013;61:1860-1870.
41. Kaul S, Diamond GA. Trial and error. How to avoid commonly encountered limitations of published clinical trials. J Am Coll Cardiol. 2010;55:415-427. doi: 10. 1016/j. jacc. 2009. 06. 065.
42. Diamond GA, Kaul S. On reporting of effect size in randomized clinical trials. Am J Cardiol. 2013;111:613-617. doi: 10. 1016/j. amjcard. 2012. 10. 047.
43. Goff SL, Mazor KM, Ting HH, Kleppel R, Rothberg MB. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis. JAMA Intern Med. 2014;174:1614-1621. doi: 10. 1001/jamainternmed. 2014. 3328.
44. Rothberg MB, Scherer L, Kashef MA, Coylewright M, Ting HH, Hu B, Zikmund-Fisher BJ. The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention. JAMA Intern Med. 2014;174:1623-1629. doi: 10. 1001/ jamainternmed. 2014. 3331.